Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Non-Current Debt (2021)

Historic Non-Current Debt for Whitehawk Therapeutics (WHWK) over the last 1 years, with Q4 2021 value amounting to $5.8 million.

  • Whitehawk Therapeutics' Non-Current Debt changed N/A to $5.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $5.8 million, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Non-Current Debt of $5.8 million as of Q4 2021.
  • Whitehawk Therapeutics' Non-Current Debt's 5-year high stood at $5.8 million during Q3 2021, with a 5-year trough of $5.8 million in Q3 2021.